Compare WAY & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WAY | MMED |
|---|---|---|
| Founded | 1999 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.5B |
| IPO Year | 2023 | 2025 |
| Metric | WAY | MMED |
|---|---|---|
| Price | $27.91 | $18.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 23 | 16 |
| Target Price | ★ $34.09 | $25.47 |
| AVG Volume (30 Days) | 2.0M | ★ 15.3M |
| Earning Date | 11-02-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 569.23 | N/A |
| EPS | ★ 0.43 | N/A |
| Revenue | $1,099,278,000.00 | ★ $3,102,000,000.00 |
| Revenue This Year | $17.00 | $10.76 |
| Revenue Next Year | $10.68 | $8.51 |
| P/E Ratio | $65.63 | ★ N/A |
| Revenue Growth | ★ 16.50 | 14.25 |
| 52 Week Low | $17.26 | $10.65 |
| 52 Week High | $37.71 | $24.43 |
| Indicator | WAY | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 54.64 | 43.90 |
| Support Level | $23.64 | $16.55 |
| Resistance Level | $29.25 | $20.88 |
| Average True Range (ATR) | 1.05 | 0.91 |
| MACD | -0.05 | 0.16 |
| Stochastic Oscillator | 59.45 | 57.03 |
Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. Its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.
While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.